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Abstract
In a follow-up study, patients are monitored over time. 
Longitudinal and time-to-event studies are the two most 
important types of a follow-up study. In this paper, the focus 
is on longitudinal studies with a continuous response where 
patients are examined at several time points. While longi-
tudinal studies provide a powerful tool for the evaluation 
of a treatment effect over time, a major problem is missing 
data caused, for example, by patients who drop out from 
the study. Many longitudinal studies in rheumatology use 
inappropriate statistical methodology because either they do 
not address correctly the correlated nature of the repeated 
measurements, or they treat the problem of missing data 
incorrectly. We will illustrate that there are interpretational 
and computational issues with the “classical” approaches. 
Further, we expand here on more appropriate statistical 
techniques to analyze longitudinal studies. To this end, we 
focus on randomized controlled trials (RCTs) and illustrate 
the approaches on data from a fictive randomized controlled 
trial in rheumatology.
In a follow-up study, patients are monitored over time. In a time-to-event study, the interest lies in recording the time until an event occurs. When the event is mortality, 
one speaks of a survival study. While the patient’s condition 
is monitored over time, (e.g. for safety reasons) in this type 
of follow-up study the repeated evaluations of the patient 
are not of primary importance; what counts is the time to 
the event.
 On the other hand, a longitudinal study, also called 
repeated measurements study, is needed when the primary 
outcome of the study needs to be monitored repeatedly over 
time. In contrast to a study where the clinical examinations 
are done only at baseline and at the end of the study, the 
longitudinal follow-up allows to monitor the rate of change 
in the response. This study type provides also a better pro-
tection against the harmful effect of missing data, as will be 
seen below.
 Of key importance to choose the appropriate statistical 
approach is the nature of the missing data process. When 
missing data occur during the conduct of the study but the 
patient stays in the study, the missing data are called inter-
mittently. But when the patient decides to leave the study, 
one says that the patient drops out from the study, and this 
missing data process is, therefore, called a dropout process. 
In the next section, we distinguish between three types of 
missing data/dropout processes. We illustrate on a fictive 
study what the effect these dropout processes may have on 
descriptive and inferential statistics. We also show that the 
classical statistical approaches fail to take into account ap-
propriately missing data.
Why Missing Data Occur or Why Do Patients 
Drop Out from a Study?
There are a variety of reasons why data fail to be collected 
in a study, ranging from pure bad luck to a process that is 
intimately related to the disease of the patient or the inter-
vention that is administered. Below we describe a classical 
taxonomy that was introduced by Little and Rubin.1,2 The 
classification determines the choice of the appropriate statis-
tical approach, but the terminology is somewhat confusing. It 
is assumed that the response of interest may be lacking, but 
that other measurements (appearing possibly as covariates 
in a regression model) are available.
 Missing-completely-at-random (MCAR): A missing re-
sponse occurs because of reasons completely unrelated to the 
response (i.e., by pure bad luck). This happens for instance 
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